Position
Chief Medical Officer
Company
Lakefront Biotherapeutics NV
Description
Lakefront Biotherapeutics NV has appointed Eric Hedrick, MD, as its new Chief Medical Officer. This position expands leadership in line with the company’s strategic transformation following a recent acquisition.
Quick answer
Lakefront Biotherapeutics Appoints Eric Hedrick as Chief Medical Officer (June 8, 2026). Lakefront Biotherapeutics NV is based in Mechelen, Antwerp, Belgium.
- Who is the new Chief Medical Officer at Lakefront Biotherapeutics NV?
- Lakefront Biotherapeutics NV named Eric Hedrick Chief Medical Officer, announced June 8, 2026.
- What did Lakefront Biotherapeutics NV announce on June 8, 2026?
- Lakefront Biotherapeutics NV has appointed Eric Hedrick, MD, as its new Chief Medical Officer. This position expands leadership in line with the company’s strategic transformation following a recent acquisition.
- What does Lakefront Biotherapeutics NV do?
- Lakefront Biotherapeutics is a biotechnology company focused on developing innovative immunotherapy treatments.
- Where is Lakefront Biotherapeutics NV based?
- Lakefront Biotherapeutics NV is based in Mechelen, Antwerp, Belgium.
- Which similar companies made leadership changes around the same time?
- Poxel (June 10, 2026), BeyondSpring (June 4, 2026), Bristol Myers Squibb (June 17, 2026) and Retension Pharmaceuticals (May 27, 2026) also announced leadership changes within 45 days of Lakefront Biotherapeutics NV.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Poxel Appoints Yves Decadt as Chief Executive Officer (June 10, 2026)
- BeyondSpring Appoints Min Qiu as Chief Executive Officer and Na Li as Chief Financial Officer (June 4, 2026)
- Bristol Myers Squibb Appoints Mayada Al-Ahmad as General Manager of Saudi Arabia and Gulf Countries (June 17, 2026)
- Retension Pharmaceuticals Appoints Alison Schecter as Chief Medical Officer and Alex Schwartz as Chief Financial Officer (May 27, 2026)
- VistaGen Therapeutics Appoints Angel S. Angelov as Chief Medical Officer (May 20, 2026)
- AVEO Pharmaceuticals Appoints Michael Ferraresso as President & CEO and Kevin A. Peacock as Chief Commercial Officer (June 30, 2026)
Who to call at Lakefront Biotherapeutics NV, and when
A new leader at Lakefront Biotherapeutics NV brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Lakefront Biotherapeutics NV raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lakefront Biotherapeutics NV, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lakefront Biotherapeutics NV. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lakefront Biotherapeutics NV changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Lakefront Biotherapeutics NV changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.